Arnold & Porter is a firm of more than 1,000 lawyers, providing sophisticated litigation and transactional capabilities, renowned regulatory experience and market-leading multidisciplinary practices in the life sciences and financial services industries. Our global reach, experience and deep knowledge allow us to work across geographic, cultural, technological and ideological borders.
On December 9, 2016, the en banc Federal Circuit will hear argument in In re Aqua Products, Inc. on an issue that has long been troubling patent owners involved in inter partes reviews (IPR)—the difficulty of amending patent claims before the Patent Trial and Appeal Board (PTAB).
Originally published in IP Watchdog on December 4,
2016.
On December 9, 2016, the en banc Federal Circuit will hear
argument in In re Aqua Products, Inc. on an issue that has
long been troubling patent owners involved in inter partes reviews
(IPR)—the difficulty of amending patent claims before the
Patent Trial and Appeal Board (PTAB).
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
